Crisugabalin Besilate
Tier C — Watch / tradeCrisugabalin Besilate
Targets：CACNA2D1
Indications (approved)：Postherpetic neuralgia, Diabetic neuropathy
Regional status
Factories producing this API2
Factories registered as producing this API in our sourcing network (RFQ records + product master), sorted by RFQ activity; the snapshot carries no cost or customer data.
2 producing factories on file — sign in to view the named list (factory details are not shown to guests).
Sign in to view factories →Synthetic routes & intermediates
Frequently asked questions
What are the approved indications of Crisugabalin Besilate?
Approved indications include: Postherpetic neuralgia, Diabetic neuropathy.
When does the Crisugabalin Besilate patent expire?
No public expiry year is available for Crisugabalin Besilate yet; this page updates once verified.
How do I get a quote for Crisugabalin Besilate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-27